[podcast]Brukinsa approval raises BeiGene’s hematology profile

cafead

Administrator
Staff member
  • cafead   Mar 20, 2024 at 09:52: PM
via BeiGene’s chief medical officer for hematology, Dr. Mehrdad Mobasher, tells Jack O’Brien about BTK inhibitor Brukinsa’s latest lymphoma approval from the FDA and offers messaging advice to medical marketers.

article source
 

<